BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 21889905)

  • 1. Current management and recommendations for access to antiviral therapy of herpes labialis.
    Cunningham A; Griffiths P; Leone P; Mindel A; Patel R; Stanberry L; Whitley R
    J Clin Virol; 2012 Jan; 53(1):6-11. PubMed ID: 21889905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antivirals for the acute treatment of recurrent herpes labialis.
    Jensen LA; Hoehns JD; Squires CL
    Ann Pharmacother; 2004 Apr; 38(4):705-9. PubMed ID: 14966254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
    Le Cleach L; Trinquart L; Do G; Maruani A; Lebrun-Vignes B; Ravaud P; Chosidow O
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009036. PubMed ID: 25086573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent herpes simplex labialis: selected therapeutic options.
    Raborn GW; Grace MG
    J Can Dent Assoc; 2003 Sep; 69(8):498-503. PubMed ID: 12954137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options for herpes labialis, I: Oral agents.
    Elish D; Singh F; Weinberg JM
    Cutis; 2004 Jul; 74(1):31-4. PubMed ID: 15293697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of topical corticosteroids in addition to antiviral therapy in the management of recurrent herpes labialis: a systematic review and meta-analysis.
    Arain N; Paravastu SC; Arain MA
    BMC Infect Dis; 2015 Feb; 15():82. PubMed ID: 25887308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose famciclovir for the treatment of herpes labialis.
    Hull C; Spruance S; Tyring S; Hamed K
    Curr Med Res Opin; 2006 Sep; 22(9):1699-702. PubMed ID: 16968573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections.
    Wu JJ; Brentjens MH; Torres G; Yeung-Yue K; Lee P; Tyring SK
    J Cutan Med Surg; 2003; 7(5):372-81. PubMed ID: 14505192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes Labialis: An Update.
    Leung AKC; Barankin B
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):107-113. PubMed ID: 28971780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment modalities and medication recommended by health care professionals for treating recurrent herpes labialis.
    Raborn GW; Chan KS; Grace M
    J Am Dent Assoc; 2004 Jan; 135(1):48-54. PubMed ID: 14959874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus infection.
    Whitley RJ
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):6-11. PubMed ID: 12118847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recurrent herpes simplex labialis infections. Possible prevention with a new therapeutic regimen].
    Harmenberg J; Spruance S
    Lakartidningen; 2010 Aug 25-31; 107(34):1918-22. PubMed ID: 20960953
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men.
    Cattamanchi A; Saracino M; Selke S; Huang ML; Magaret A; Celum C; Corey L; Wald A; Casper C
    J Med Virol; 2011 Oct; 83(10):1696-703. PubMed ID: 21837785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Famciclovir for cutaneous herpesvirus infections: an update and review of new single-day dosing indications.
    Chacko M; Weinberg JM
    Cutis; 2007 Jul; 80(1):77-81. PubMed ID: 17725069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.
    Schiffer JT; Magaret A; Selke S; Corey L; Wald A
    J Antimicrob Chemother; 2011 Nov; 66(11):2593-600. PubMed ID: 21865349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis.
    Bacon TH; Boon RJ; Schultz M; Hodges-Savola C
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3042-4. PubMed ID: 12183267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
    Hull CM; Brunton S
    Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Famciclovir/penciclovir.
    Sacks SL; Wilson B
    Adv Exp Med Biol; 1999; 458():135-47. PubMed ID: 10549386
    [No Abstract]   [Full Text] [Related]  

  • 19. An update on short-course intermittent and prevention therapies for herpes labialis.
    Gilbert S; Corey L; Cunningham A; Malkin JE; Stanberry L; Whitley R; Spruance S
    Herpes; 2007 Jun; 14 Suppl 1():13A-18A. PubMed ID: 17877887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.
    Baker D; Eisen D
    Cutis; 2003 Mar; 71(3):239-42. PubMed ID: 12661753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.